ChromaDex Corporation

NASDAQ:CDXC

3.55 (USD) • At close September 18, 2024
Bedrijfsnaam ChromaDex Corporation
Symbool CDXC
Munteenheid USD
Prijs 3.55
Beurswaarde 269,562,505
Dividendpercentage 0%
52-weken bereik 1.25 - 4.65
Industrie Biotechnology
Sector Healthcare
CEO Mr. Robert N. Fried
Website https://www.chromadex.com

An error occurred while fetching data.

Over ChromaDex Corporation

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to

Vergelijkbare Aandelen

Checkpoint Therapeutics, Inc. logo

Checkpoint Therapeutics, Inc.

CKPT

2.46 USD

CVRx, Inc. logo

CVRx, Inc.

CVRX

8.69 USD

UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

URGN

13.1 USD

Annexon, Inc. logo

Annexon, Inc.

ANNX

6.93 USD

Portage Biotech Inc. logo

Portage Biotech Inc.

PRTG

9.91 USD

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

2.22 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)